Skip to content

Effects of remote counseling telepharmacy program in patients with pulmonary tuberculosis

Effects of remote counseling telepharmacy program in patients with pulmonary tuberculosis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250816001
Enrollment
24
Registered
2025-08-16
Start date
2023-11-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed with pulmonary tuberculosis, confirmed by a positive sputum test result . Pulmonary Tuberculosis, Outpatients, Medication Adherance, Telemedicine, Pharmacists, Counseling, Pharmaceutical Services

Interventions

Standard pharmaceutical care included the following 1. In-person counseling on tuberculosis disease, self-care, medications, and potential adverse effects at treatment initiation 2. Identification and
No Intervention Other,Experimental Other
Standard Pharmaceutical Care,Pharmacist-led Telepharmacy-TB Program and Standard Pharmaceutical Care

Sponsors

Ubon Ratchathani University
Lead Sponsor
The Doctorkasem foundation.org
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. In possession of a mobile phone with internet access and the LINE application installed, and 3. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. A diagnosis of bipolar disorder or other psychiatric disorders 2. Receiving palliative care 3. Dementia 4. Residence in a prison facility 5. Drug-resistant tuberculosis 6. Inability to communicate in Thai

Design outcomes

Primary

MeasureTime frame
Sputum smear conversion At the end of the 2-month intensive phase Acid-Fast Bacilli smear test,Chest X-ray evaluation At the end of the 2-month intensive phase Chest X-ray

Secondary

MeasureTime frame
Medication Adherence At Weeks 2 and 8 after treatment initiation. 1. A self-reported questionnaire 2. The pill count method ,Knowledge of Tuberculosis and Anti-TB Drugs At Weeks 2 and 8 after treatment initiation. Questionaire,Drug-Related Problems Intervention group: Daily during the 8-week intensive phase, plus assessments at Weeks 2 and 8 after treatment initiation. Control group: Assessments at Weeks 2 and 8 after treatment initiation. Pharmaceutical care form (standard care),Patient Satisfaction with the Telepharmacy Program Intervention group: Assessment at Week 8 after treatment initiation. Patient satisfaction questionnaire

Countries

Thailand

Contacts

Public ContactNapapak Yotarak

Chao Phraya Abhaibhubejhr Hospital

napapak.yo.65@ubu.ac.th037 211 088

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026